Health Management

Insight from Paul Markovich, CEO, Blue Shield of California

Personalization is the key to a healthcare experience that optimizes outcomes, improves the customer experience and, ultimately, lowers costs to the healthcare system. Find out why it’s especially key for diabetic patients.

Mobile health (mHealth) offers new ways to empower patients with diabetes in caring for themselves and making decisions that support their health.

Like any medication, benzodiazepines should be used with caution. However, the tremendous expenditure for these medications-just a year after Medicare Part D extended its coverage to include them in 2012-has some wondering why so many of these drugs are being prescribed.

Staying compliant with a prescribed treatment regimen gives cardiovascular disease patients the best chance of improving their heart health and reducing future incidences of cardiac events. Here’s how to get patients on board.

A report from the Department of Health and Human Services indicates positive momentum in efforts to combat hospital-acquired conditions, but experts say more can be done.

Heart disease takes a heavy toll on the healthcare system, but promising new treatments are emerging

Health plans and PBMs that are reluctant to invest in mobile tools for their covered members will miss out.

Study demonstrates how new technology can drive higher value healthcare for heart failure patients.

The death rate from overdoses involving benzodiazepines, a class of sedatives that includes Xanax, Valium, and Klonopin, has increased more than four-fold since 1996, according to a study appearing online in the American Journal of Public Health.

Medicare Advantage plans that are slow to submit risk adjustment data are at a big disadvantage.

Telemedicine could improve diabetic patient outcomes, expand access, and provide better economic value for patients. Find out how.

Consequences range from cardiovascular disease to renal disease

Here are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.

There is so much data available at all levels of healthcare, and technology and public support is on the cusp of a breakthrough in using this information for widespread improvements.

A successful YMCA diabetes program has prompted the Obama administration to expand Medicare to cover programs to prevent diabetes among those at high risk of developing the disease.

The sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations.

… and solutions from experts

In the move to value-based care, there have been surprises and disruptions for payers and providers alike. In this Q&A, an expert shares where we are now.

As alternative payment models gain traction, payers and providers must take the appropriate steps to thrive.

Ensuring the appropriate internal investment, addressing key friction points, and taking several steps to increase the likelihood of long-term success is key.

The 2016 Alternative Payment Models in Healthcare Conference 2016 is shedding light on which healthcare payment and delivery changes are evolving into large-scale, long-lasting solutions.

Shared resources, specialized drugs key to curbing costs

Rob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients.

Considering entering into a risk-sharing agreement with another payer or provider? Avoid these top mistakes.